Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346188 · ClinicalTrials.gov registry record · NA
Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 602
- Enrollment target
NCT02346188 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 602 participants.
The verdict
NCT02346188, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 602 participants
- Enrollment target
Study Summary
Lead is negatively linked to nutritional status, behavior and cognition in children. Despite extensive knowledge of its toxicity and efforts to reduce exposure, lead continues to be a problem in developed and developing countries. When lead exposure is unavoidable due to its pervasive nature, effective means of protecting or disrupting that exposure need to be developed. Nutritional interventions are one such option. We conducted a 2x2 factorial, placebo-controlled trial of 6-month iron and zinc supplementation among lead-exposed children in Torreón, Mexico (altitude 1060 m). Nine schools were selected based on proximity to a lead smelter and first-graders were individually randomized to daily treatment with 30 mg iron, 30 mg zinc, both, or placebo. In addition to biochemical indicators, cognitive functions and behavior were evaluated at baseline, after the 6-month supplementation period, and again after another 6 months (without supplementation). At baseline, 602 children ages 6.2-8.5 years were enrolled.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Ferrous fumarate
- DIETARY_SUPPLEMENT Zinc oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2000-01 |
| Est. Completion | 2001-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02346188
The ClinicalTrials.gov registry entry for NCT02346188 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02346188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02346188 about?
NCT02346188 is a clinical study titled "Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead". Lead is negatively linked to nutritional status, behavior and cognition in children. Despite extensive knowledge of its toxicity and efforts to reduce exposure, lead continues to be a problem in developed and developing countries. When lead exposure is unavoidable due to its pervasive nature, effect...
What is the current status of trial NCT02346188?
This trial is currently completed. It is a NA study. The enrollment target is 602 participants. The study started on 2000-01. Estimated completion is 2001-12.
What interventions are being tested in trial NCT02346188?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Ferrous fumarate (DIETARY_SUPPLEMENT), Zinc oxide (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02346188?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.